| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director
2 companies
Hastings Paul J is a Chief Executive Officer at NKTX with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2018 | PCRX Pacira Biosciences, Inc. | Director | Sell | 771 | $33.90 | $26,136.90 | -21.9% | |
| Aug 22, 2017 | PCRX Pacira Biosciences, Inc. | Director | Sell | 1,044 | $36.15 | $37,740.60 | -22.9% | |
| Jun 6, 2016 | PCRX Pacira Biosciences, Inc. | Director | Sell | 1,136 | $46.95 | $53,335.20 | -39.8% | |
| Feb 17, 2016 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Nov 20, 2015 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Aug 17, 2015 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 3,000 | $60.02 | $180,060.00 | -51.3% | |
| Apr 10, 2015 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 2,500 | $88.00 | $220,000.00 | -74.6% | |
| Jan 12, 2015 | PCRX Pacira Biosciences, Inc. | Director | Sale+OE | 2,500 | $94.06 | $235,150.00 | -74.6% |